Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 25

Results For "non"

1704 News Found

ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
Clinical Trials | April 24, 2026

ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma

The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack


Medix Biochemica elevates Petra Furu to CEO role
People | April 23, 2026

Medix Biochemica elevates Petra Furu to CEO role

With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector


PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
Clinical Trials | April 22, 2026

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev


Zyax Chem takes 26% stake in Gaymed Labs
News | April 22, 2026

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push


Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0
Public Health | April 22, 2026

Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0

Policy symposium in Hyderabad focuses on life skills education and community?driven solutions